Hamstring tendon autograft ACL reconstruction: ACL reconstruction using ipsilateral hamstring tendon autograft (semitendinosus and gracilis tendons) with arthroscopic technique
Quadriceps tendon autograft ACL reconstruction: ACL reconstruction using ipsilateral quadriceps tendon autograft with arthroscopic technique
Study summary
This prospective multicenter cohort study aims to compare clinical and functional outcomes between hamstring tendon and quadriceps tendon autografts in anterior cruciate ligament (ACL) reconstruction in female athletes. Participants will be followed for two years after surgery to evaluate graft failure rates, return to sport, knee stability, and patient-reported outcomes.
Eligibility
Sex
FEMALE
Min age
16 Years
Max age
35 Years
Healthy volunteers
No
Inclusion Criteria:
* Female patients aged 16 to 35 years with skeletal maturity
* Active athlete: minimum two training sessions per week during the six months prior to injury in pivoting sports
* Confirmed complete ACL rupture by MRI and clinical examination
* Primary ACL reconstruction (first ligament surgery on the index knee)
* Time from injury to surgery no longer than 6 months
* Signed informed consent
Exclusion Criteria:
* Previous ligament surgery on either knee
* Multiligament injury: simultaneous PCL, grade III MCL or LCL injury
* Neuromuscular, rheumatological or systemic pathology interfering with rehabilitation or functional assessments
* Pre-existing radiological osteoarthritis grade Kellgren-Lawrence ≥2 in the index knee
* Inability to complete 24-month follow-up protocol
* Pregnancy at inclusion or during follow-up period
Primary outcome measure(s)
Graft failure rate — 24 months after surgery Proportion of patients requiring revision ACL reconstruction or presenting with objetive graft rupture confirmed by MRI or arthroscopy
Trial sites (1)
Facility
City
Region
Status
IMED Hospitales
Alicante
Alicante
More Universidad Católica San Antonio de Murcia trials in Spain
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.